Domino Data Lab Joins Accenture’s INTIENT Network to Help Drive Innovation in Clinical Research
December 2, 2020
*** MEDIA ALERT ***
Domino Data Lab, provider of the leading open enterprise data science management platform trusted by over 20% of the Fortune 100, has joined Accenture’s INTIENT Network partner ecosystem – designed to accelerate drug discovery and development efforts in partnership with software and life sciences organizations to improve patient outcomes. The Accenture INTIENT Clinical Managed Analytics Environment is built on the Domino Data Science Platform as the core workbench, delivering an end-to-end clinical trial solution for pharmaceutical companies.
The INTIENT Network is integral to Accenture’s INTIENT Platform. It enables insights and collaboration across the life sciences enterprise to improve productivity, efficiency and innovation in drug discovery to clinical studies. Accenture works with select independent software vendors (ISVs) and organizations, including Domino Data Lab, to integrate their technologies and content into the INTIENT Clinical product suite. With the help of Domino’s data science platform, life sciences teams can now successfully test tens of thousands of hypotheses with collaboration and full reproducibility.
The Domino platform will be available to life sciences companies within a common informatics framework that handles core infrastructure requirements such as data ingestion and cleansing, security and IP management, request management workflow, enterprise search, data governance, and collaboration environments.
The Domino platform centralizes data science work and infrastructure across the enterprise for collaborative model development, training, deployment, and overall life cycle management – with agility and efficiency. With Domino, scientists and researchers can innovate faster; teams collaborate and build on prior works with security, oversight and compliance. Data science leaders gain greater visibility into projects, and IT teams can manage and govern infrastructure usage and costs. For more information on the platform visit the website.
“It’s an honor to be a core member of Accenture’s INTIENT Network, providing the platform that underpins INTIENT’s managed analytics environment,” said Nick Elprin, CEO and co-founder at Domino Data Lab. “By providing the Domino Data Science Platform as a SaaS offering for life sciences teams, we bring our expertise working with global health and life sciences research organizations on clinical trial workflows to a new set of pharmaceutical companies driven to propel research innovation. Customers gain a centralized research platform that offers security and scalability with technology and tool choice.”
“Our partner network is one way that we differentiate our market approach and bring ongoing innovation to our Accenture INTIENT clients, enabling collaboration and insights across the life sciences enterprise,” said Geoffrey Schmidt, managing director, Accenture Life Sciences. “Domino Data Lab’s participation in the ecosystem and integration with INTIENT will give clinical researchers a crucial workbench that will support their quest to interpret growing volumes of rich, diverse data that are generated in drug development.”
About Domino Data Lab
Domino Data Lab empowers data science teams with the leading, open data science platform that enables enterprises to manage and scale data science with discipline and maturity. Model-driven companies including Allstate, Dell Technologies, and Bayer use Domino as a data science system of record to accelerate breakthrough research, increase collaboration, and rapidly deliver high-impact models. Founded in 2013 and based in San Francisco, Domino is backed by Sequoia Capital, Coatue, Bloomberg Beta, Dell Technologies Capital, Highland Capital Partners, and Zetta Venture Partners. For more information, visit dominodatalab.com.